Additionally, exogenous ERDR1 treatment decreases cancer cell proliferation and tumor growth in melanoma as a result of increased apoptosis via the regulation of apoptosis-related molecules—Bcl-2 and Bax. This evidence concerns the gene BCL2 and neoplasm.